SCHEMBL64709

SCHEMBL64709

CCOC(=O)C(C)(OC(C)=O)C(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.46
HSD17B10 Q99714 1/20 0.46
GAA P10253 2/20 0.43
PKM P14618 3/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP4F2 P78329 3/20 0.39
CYP4A11 Q02928 3/20 0.39
THRB P10828 1/20 0.39
HTT P42858 1/20 0.38
MMP8 P22894 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RECQL P46063 1/20 0.36
MAPT P10636 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ABCB11 O95342 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27708472 0.80 PKM (0.39) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL27323086 0.79 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10GAAPKM
SCHEMBL4672818 0.78 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10GAAPKM
Alcohol SCHEMBL12986864 0.78 GAA (0.50) ALDH1A1LMNAHSD17B10GAATSHR
SCHEMBL2403192 0.77 GAA (0.52) ALDH1A1LMNAHSD17B10GAATSHR
SCHEMBL29135298 0.75 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10GAAPKM
SCHEMBL20621933 0.75 PKM (0.37) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL262119 0.73 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10GAAPKM
SCHEMBL556528 0.73 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10GAAPKM
SCHEMBL9416752 0.73 CYP4F2 (0.44) ALDH1A1LMNAHSD17B10GAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595466-B2 NKR variants for increased production of isobutanol GEVO, INC. (US) 2026-04-07 US disclosed
WO-2025049848-A2 PROTEASES AND ALDC ENZYMES FOR BEER HAZE AND DIACETYL REDUCTION INTERNATIONAL N&H DENMARK APS (DK) 2025-03-06 WO disclosed
US-20230332130-A1 ACETOLACTATE DECARBOXYLASE INTERNATIONAL N&H DENMARK APS (DK) 2023-10-19 US disclosed
US-20230295601-A1 ALDC PRODUCTION METHODS INTERNATIONAL N&H DENMARK APS (DK) 2023-09-21 US disclosed
CN-107636151-B Acetolactate decarboxylase 杜邦营养生物科学有限公司 2023-04-04 CN disclosed
EP-4155399-A1 ACETOLACTATE DECARBOXYLASE DuPont Nutrition Biosciences ApS (DK) 2023-03-29 EP disclosed
US-20230087872-A1 NOVEL NKR VARIANTS FOR INCREASED PRODUCTION OF ISOBUTANOL GEVO, INC. 2023-03-23 US disclosed
US-11578316-B2 Acetolactate decarboxylase variants having improved specific activity DUPONT NUTRITION BIOSCIENCES APS (DK) 2023-02-14 US disclosed
EP-4114917-A1 NOVEL NKR VARIANTS FOR INCREASED PRODUCTION OF ISOBUTANOL GEVO, Inc. (US) 2023-01-11 EP disclosed
EP-3298138-B1 ACETOLACTATE DECARBOXYLASE DUPONT NUTRITION BIOSCI APS (DK) 2022-08-10 EP disclosed
US-20110201090-A1 Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals, and amino acids GEVO, INC. (US) 2011-08-18 US disclosed
US-20110201072-A1 Modified alcohol dehydrogenases for the production of fuels and chemicals GEVO, INC. (US) 2011-08-18 US disclosed
US-7910342-B2 Transgenic escherichia for use as bioreactor in conversion of acetolactate to dihydroxy-isovalerate; fuel additive; feedstock chemical in plastics; food and flavorings BUTAMAX(TM) ADVANCED BIOFUELS LLC (US) 2011-03-22 US disclosed
EP-2222841-A2 KETOL-ACID REDUCTOISOMERASE USING NADH ButamaxTM Advanced Biofuels LLC (US) 2010-09-01 EP disclosed
US-20100197519-A1 KETOL-ACID REDUCTOISOMERASE USING NADH E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-08-05 US disclosed
EP-2134849-A2 FERMENTIVE PRODUCTION OF ISOBUTANOL USING HIGHLY ACTIVE KETOL-ACID REDUCTOISOMERASE ENZYMES E. I. Du Pont de Nemours and Company (US) 2009-12-23 EP disclosed
WO-2009085953-A2 KETOL-ACID REDUCTOISOMERASE USING NADH E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-07-09 WO disclosed
US-20090163376-A1 KETOL-ACID REDUCTOISOMERASE USING NADH E.I. DU PONT DE NEMOURS AND COMPANY 2009-06-25 US disclosed
WO-2008130995-A2 FERMENTIVE PRODUCTION OF ISOBUTANOL USING HIGHLY ACTIVE KETOL-ACID REDUCTOISOMERASE ENZYMES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-10-30 WO disclosed
US-20080261230-A1 FERMENTIVE PRODUCTION OF ISOBUTANOL USING HIGHLY ACTIVE KETOL-ACID REDUCTOISOMERASE ENZYMES GEVO, INC. 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595466-B2 NKR variants for increased production of isobutanol TKT, DCXR, AKR1C1 ALDH1A1 527/4885LMNA 3097/4885HSD17B10 169/4885
US-20100197519-A1 KETOL-ACID REDUCTOISOMERASE USING NADH COASY, ME1, ADH7 ALDH1A1 513/4885LMNA 3977/4885HSD17B10 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.